Reading room

Terapia March 2023 NR 3 ( 422 )

Diabetology

Editor of the issue: prof. dr hab. n. med. Leszek Czupryniak

Contents:

Latest developments in pump therapy for type 1 diabetes

    Authors:
  • dr n. med. Elektra Szymańska-Garbacz
  • prof. dr hab. n. med. Leszek Czupryniak
Keywords: diabetes type 1, guidelines, insulin pumps, "artificial pancreas", telemedicine

Continuous glucose monitoring systems in the management of patients with type 1 diabetes, also those with impaired hypoglycemia awareness – review of the evidence

    Authors:
  • prof. dr hab. n. med. Dorota Zozulińska-Ziółkiewicz
  • prof. dr hab. n. med. Małgorzata Myśliwiec
  • prof. dr hab. n. med. Maciej Małecki
  • prof. dr hab. n. med. Agnieszka Szadkowska
  • prof. dr hab. n. med. Przemysława Jarosz-Chobot
  • prof. dr hab. n. med. Janusz Gumprecht
  • dr n. med. Bogumił Wolnik
  • mgr Monika Reczek
  • mgr Monika Małowicka
  • mgr Natalia Kowalczuk
  • dr n. med. Przemysław Ryś
  • dr n. med. Jakub Gierczyński, MBA
  • dr n. ekon. Małgorzata Gałązka-Sobotka
  • prof. dr hab. n. med. Leszek Czupryniak
Keywords: type 1 diabetes, continuous glucose monitoring systems, hypoglycemia, impaired awareness of hypoglycemia

Continuous glucose monitoring for every diabetic patient?

    Authors:
  • dr n. med. Bogumił Wolnik
Keywords: diabetes, continuous glucose monitoring, hypoglycemia, glucose variability

Modern type 2 diabetes treatment paradigm and why it should implemented at its earliest

    Authors:
  • prof. dr hab. n. med. Leszek Czupryniak
Keywords: type 2 diabetes, SGLT-2 inhibitors, GLP-1 receptor agonists, cardiovascular risk

DPP-4 inhibitors – antidiabetic agents rediscovered

    Authors:
  • prof. dr hab. n. med. Leszek Czupryniak
Keywords: type 2 diabetes, DPP-4 inhibitors, incretin based therapies, sitagliptin, vildagliptin

SGLT-2 inhibitors - from diabetology to cardiology

    Authors:
  • lek. Katarzyna Wójcik
  • dr n. med. Elżbieta Wójcik-Sosnowska
Keywords: SGLT2 inhibitors in diabetes, SGLT2 inhibitors in heart failure, chronic kidney disease and SGLT-2 inhibitors, diabetic nephropathy treatment, non-hypoglycaemic effect of SGLT-2 inhibitors

GLP-1 analogs in the treatment of diabetes, obesity and...?

    Authors:
  • dr hab. n. med. Mariusz Dąbrowski, prof. uczelni
Keywords: type 2 diabetes, obesity, GLP-1 receptor agonists, cardiovascular disease, chronic kidney disease, fatty liver disease, neurodegenerative diseases

Metformin therapy during pregnancy

    Authors:
  • lek. Katarzyna Wójcik
  • dr n. med. Elżbieta Wójcik-Sosnowska
Keywords: metformin, pregnancy, metformin therapy during pregnancy, metformin therapy PCOS, metformin vs insulin

Diabetic foot syndrome (DFS) - the rules for optimal management in the outpatient setting or how to avoid pitfalls in the daily diagnosis and treatment of DFS

    Authors:
  • lek. Tomasz Głażewski
  • lek. Karolina Facca
  • prof. dr hab. n. med. Leszek Czupryniak
Keywords: diabetic foot syndrome, amputation, offloading, debriding, endovascular surgery, antibiotics therapy

Current therapeutic options in prediabetes

    Authors:
  • lek. Anna Durma
  • lek. Monika Blicharska
  • prof. dr hab. n. med. Leszek Czupryniak
Keywords: glucose intolerance, prediabetes, lifestyle intervention, metformin, SGLT2 inhibitors, GLP-1 analogues

Intestinal microbiota and diabetes - the most important is invisible to the eyes

    Authors:
  • dr hab. n. med. Katarzyna Nabrdalik, prof. SUM
  • dr n. med. i n. o zdr. Hanna Kwiendacz
  • prof. dr hab. n. med. Janusz Gumprecht
Keywords: intestinal microbiota, dysbiosis, obesity, diabetes